Latest Us Expansion News

UC San Diego Health has begun clinical use of 4DMedical’s CT – VQ™, marking the fourth leading US academic medical centre to adopt this innovative lung imaging technology since FDA clearance. This milestone underscores 4DMedical’s rapid commercial traction and growing influence in respiratory diagnostics.

Orthocell has reported a record $3.2 million in quarterly revenue, marking its seventh consecutive quarter of growth, driven by strong sales of its Remplir™ nerve repair product in Australia and early traction in the US market.

Metallium’s US subsidiary has locked in a binding multi-year supply agreement with Glencore for electronic scrap, underpinning the commercial scale-up of its innovative Flash Joule Heating technology in Texas.

AVA Risk Group has locked in a strategic investment of up to A$12.6 million from US-based Hale Capital, aiming to boost its footprint in the lucrative US critical infrastructure market. The deal includes convertible notes and warrants priced at an 81% premium, alongside a new board appointment.

Cobram Estate Olives Limited has agreed to acquire California Olive Ranch, a leading US extra virgin olive oil producer, for US$173.5 million, significantly boosting its US footprint and expected to add 9% EPS accretion by FY27. The deal positions Cobram Estate as a major player in the fast-growing American EVOO market.

Ovanti Limited has raised $3 million through a discounted share placement to fund its expansion into the US buy now, pay later market and support ongoing litigation.

Galilee Energy has appointed three new directors, including CEO Joseph Graham as Managing Director, to align its leadership with its strategic pivot to the Zydeco Gas Project in Louisiana. This board refresh signals a new chapter focused on growth in the US energy sector.

Renegade Exploration has secured an option to acquire the Rooster Hill Monazite Project in Wyoming, tapping into a historically promising rare earth element resource. The move expands Renegade’s US footprint amid rising demand for critical minerals.

Talga Group has opened a $5 million Share Purchase Plan at $0.41 per share, offering shareholders free attaching and piggyback options to support its planned anode production ramp-up and US expansion.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.

Genetic Signatures announces the upcoming departure of CEO Allison Rossiter, initiating a leadership transition as the company intensifies its focus on US market expansion.